Viimane versioon :
01/07/2024
Infostab
Ingredientide nimekiri
Nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
Uurimisrühmad
Valistab
Plakat
Sidemed
Sponsorid
Autor
Kasutusjuhend
Ajakiri
Viited 4768
Tüüp :
Ajaleht
Uurimisrühmad :
Tokyo - Nippon Medical School Hospital, Department of Pharmacy
Autor :
Kondo M, Genpei M, Watanabe K, Yoshida M, Tagui N, Fukao S, Sugaya K, Takase H.
Pealkiri :
Y-site injection physical compatibility of remdesivr with select intravenous drugs used in palliative care and for treating coronavirus disease 2019.
Publikatsioon :
Journal of Nippon Medical school 2023
Tõendite tase :
Füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
Ingredientide nimekiri
Fentanyl citrate
50 µg/ml
+
Remdesivir
1 mg/ml
+
Furosemide
10 mg/ml
+
Remdesivir
1 mg/ml
+
Heparin sodium
1000 UI/ml
+
Remdesivir
1 mg/ml
+
Hydromorphone hydrochloride
1 mg/ml
+
Remdesivir
1 mg/ml
+
Morphine hydrochloride
10 mg/ml
+
Remdesivir
1 mg/ml
+
Octreotide acetate
0,030 mg/ml
+
Remdesivir
1 mg/ml
+
Oxycodone hydrochloride
10 mg/ml
+
Remdesivir
1 mg/ml
+
Remdesivir
1 mg/ml
+
1 mg/ml
+
1 mg/ml
+
Fentanyl citrate
50 µg/ml
+
1 mg/ml
+
Furosemide
10 mg/ml
+
1 mg/ml
+
Heparin sodium
1000 UI/ml
+
1 mg/ml
+
Hydromorphone hydrochloride
1 mg/ml
+
1 mg/ml
+
Morphine hydrochloride
10 mg/ml
+
1 mg/ml
+
Octreotide acetate
0,030 mg/ml
+
1 mg/ml
+
Oxycodone hydrochloride
10 mg/ml
+
Mentions Légales